Actively Recruiting
The Safety and Efficacy of Radiofrequency Ablation After Left Atrial Appendage Occlusion.
Led by Affiliated Hospital of Nantong University · Updated on 2025-05-22
210
Participants Needed
1
Research Sites
162 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Objective: To evaluate the safety and efficacy of transcatheter atrial fibrillation ablation 1 month after WATCHMAN FLX left atrial appendage closure in patients with nonvalvular atrial fibrillation.
CONDITIONS
Official Title
The Safety and Efficacy of Radiofrequency Ablation After Left Atrial Appendage Occlusion.
Who Can Participate
Eligibility Criteria
You may qualify if you...
- 18 years or older with diagnosed nonvalvular atrial fibrillation
- Eligible for WATCHMAN FLX left atrial appendage closure and transcatheter atrial fibrillation ablation
- Suitable left atrial appendage anatomy for WATCHMAN FLX implantation based on preoperative imaging
- Agree to participate and provide informed consent
You will not qualify if you...
- Valvular heart disease or other structural heart disease causing atrial fibrillation
- Presence of left auricular thrombus or acute thrombotic event before surgery
- Severe bleeding tendency or recent major bleeding events such as gastrointestinal bleeding or cerebral hemorrhage
- Unable to complete postoperative follow-up due to limited life expectancy or poor compliance
- Serious diseases found in preoperative exams like liver or kidney failure, active infection
- Pregnant or breastfeeding women
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Affiliated hospital of Nantong University
Nantong, Jiangsu, China, 226001
Actively Recruiting
Research Team
Q
Qi Lu MD
CONTACT
J
Jian Zhang MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here